ArticleScientific reports2025
Ultrasound-guided femoral venous access decreases vascular complications in catheter ablation procedures.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Patient satisfaction and complication rates in ultrasound-guided procedures: A questionnaire-based analysis.Bioinformation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ultrasound (US) guidance is increasingly used in invasive cardiac electrophysiology (EP) procedures for femoral vascular access. In this study, we assessed the occurrence of vascular access-related complications in EP procedures which were performed with the routine use of anatomical landmark (LM) versus US-guided vascular access. A total of 1119 consecutive EP procedures in 1012 patients performed in a two-year period from September 10, 2020 to September 10, 2022 were included. The endpoint of the present study consisted of any vascular access-related complication, classified as hematoma, aneurysm, or AV-fistula. Different risk factors for increased bleeding risk were analyzed. During the evaluation period, 777 procedures were performed using LM-guiding and 342 procedures using US-guided access. Overall, 19 (1.7%) relevant vascular complications occurred including: 15 (1.3%) hematoma, 2 (0.18%) aneurysm and 2 (0.18%) AV-fistula. 17 (2.2%) complications occurred in the LM-guided group and 2 (0.6%) in the US-guided group. A significant reduction of femoral complications by 89% was observed with introduction of routine US-guided access. 3.8% in the LM-group vs. 0.4% in the US-group (OR 0.1, 95% CI 0.0135-0.8515, p = 0.034). Intraprocedural ACT and the HASBLED score [range 0-4; mean = 1.47; maximum = 4) were shown to be independent predictors for vascular complications (OR 2.826, 95% CI 1.631-4.895, p < 0.001). The use of US-guided vascular access significantly decreased the access-related complication rate in EP procedures. Higher procedural ACT and HASBLED score independently predicted a higher risk of vascular access complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.